Clinical trial
A Phase 4, Randomized, Single-blind Trial to Evaluate Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine When Administered Simultaneously With Trivalent Inactivated Influenza Vaccine in Healthy Children Aged 3-7years and Healthy Adults 65 Aged 50-65years.
NCT02062281 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 4, Randomized, Single-blind Trial to Evaluate Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine When Administered Simultaneously With Trivalent Inactivated Influenza Vaccine in Healthy Children Aged 3-7years and Healthy Adults 65 Aged 50-65years.
- Lead sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- January 31, 2014
- Enrollment
- 2,225 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza, pneumococcal infection